Last reviewed · How we verify
Hereditary factor XIII A subunit deficiency
Approved treatments
- Novothirteen · Novo Nordisk
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hereditary factor XIII A subunit deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Hereditary factor XIII A subunit deficiency treatment landscape brief
- Hereditary factor XIII A subunit deficiency treatment updates RSS
Frequently asked questions about Hereditary factor XIII A subunit deficiency
What drugs treat Hereditary factor XIII A subunit deficiency?
Tracked treatments include Novothirteen.
What is the treatment for Hereditary factor XIII A subunit deficiency?
Standard treatment for Hereditary factor XIII A subunit deficiency includes Novothirteen. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hereditary factor XIII A subunit deficiency patent cliff · Hereditary factor XIII A subunit deficiency CI report
- Treatment: Novothirteen · Novo Nordisk
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing